Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Data To Support Communications To Educate Consumers on How To Safely Purchase Drugs Online, 64949-64950 [2011-27019]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 202 / Wednesday, October 19, 2011 / Notices
Dated: September 26, 2011.
Earl S. Johnson,
Director, Office of Family Assistance.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
BILLING CODE 4184–35–P
Office of Family Assistance,
ACF, HHS.
ACTION: Award of a Single-source Grant
to The WorkPlace, Inc., a local
workforce investment board located in
Bridgeport, CT.
AGENCY:
Statutory Authority: Section 2008(a) of
Title XX of the Social Security Act, as
amended by Section 5507 of the Affordable
Care Act (Pub. L. No. 111–148).
The Administration for
Children and Families (ACF), Office of
Family Assistance (OFA), Health
Profession Opportunity Grants (HPOG)
program announces the award of a
single-source grant (cooperative
agreement) to The WorkPlace, Inc. a
local, non-profit workforce investment
board located in Bridgeport, CT. Award
funds will support a program to provide
education and training to Temporary
Assistance to Needy Families (TANF)
recipients, and other low-income
individuals, for occupations in the
health care field that pay well and are
expected to either experience labor
shortages or be in high demand.
The city of Bridgeport, CT, faces high
levels of unemployment. The
WorkPlace, Inc., proposes working with
numerous community partners to
coordinate referrals, conduct
assessments, and provide remedial and
life skills training, supportive services,
and occupational skills training.
If performance by the grantee is
deemed satisfactory and funds are
available, the grantee may be awarded
future funding in the form of annual
noncompetitive continuation grants.
DATES: The project period for the award
is September 30, 2011–September 29,
2012.
FOR FURTHER INFORMATION CONTACT: Stan
Koutstaal, Program Manager, Office of
Family Assistance, 370 L’Enfant
Promenade, SW., Washington, DC
20447. Telephone: 202–401–5457; Email: stanley.koutstaal@acf.hhs.gov.
SUMMARY:
emcdonald on DSK5VPTVN1PROD with NOTICES
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2011–27067 Filed 10–18–11; 8:45 am]
Notice of the Award of a Single-Source
Grant to The WorkPlace, Inc., in
Bridgeport, CT
Data To Support Communications To
Educate Consumers on How To Safely
Purchase Drugs Online—(OMB Control
Number 0910–NEW)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0494]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Data To Support
Communications To Educate
Consumers on How To Safely
Purchase Drugs Online
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
64949
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by November
18, 2011.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, Fax: 202–
395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Data to Support Communications
to Educate Consumers on How to Safely
Purchase Drugs Online.’’ Also include
the FDA docket number found in
brackets in the heading of this
document.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Juanmanuel Vilela, Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–7651,
Juanmanuel.vilela@fda.hhs.gov.
FDA has planned an integrated public
outreach campaign to improve the safe
use of online pharmacies for drug
purchases. In order to effectively
evaluate this campaign, FDA must
understand individuals’ knowledge,
attitudes, and practices with regard to
online pharmacies both at the start of
the campaign and on an ongoing basis.
This will enable FDA to gauge progress
toward educating the public on safely
purchasing from online pharmacies. An
online survey panel will be employed to
collect this information, which serves
the need for direct and quantitative
measurement of our target population,
and which, as a quantitative research
tool has some major benefits:
• To focus on our target population of
adults who use the Internet.
• To collect data quickly and
efficiently with minimal cost to the
government.
• To reduce burden to the public by
providing a means to complete the
survey at a time and place of their
choosing.
FDA will use online data collection to
establish a baseline and evaluate the
success of its messages and distribution
methods for its outreach campaign,
which educates consumers about how to
safely purchase drugs online.
Additionally, FDA will use this method
to help tailor messages and
communications vehicles to have both a
more powerful and desired impact on
target audiences. The data will not be
used for the purposes of making policy
or regulatory decisions.
In the Federal Register of July 12,
2011 (76 FR 40920), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. FDA received no
comments.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Activity
Number of
respondents
Number of
responses per
respondent
Total annual
responses
Average burden
per response
Total hours
Survey Study ..................................................................
5,000
1
5,000
.33 (20 min.)
1,650
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
VerDate Mar<15>2010
16:34 Oct 18, 2011
Jkt 226001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
E:\FR\FM\19OCN1.SGM
19OCN1
64950
Federal Register / Vol. 76, No. 202 / Wednesday, October 19, 2011 / Notices
Annually, FDA projects one survey
study. FDA is requesting this data
collection burden so as not to restrict
the Agency’s ability to gather
information on public sentiment for its
proposals in its regulatory and
communications programs.
Dated: October 14, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–27019 Filed 10–18–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0510]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Substances
Prohibited From Use in Animal Food or
Feed
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by November
18, 2011.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0627. Also
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Juanmanuel Vilela, Office of
Information Management, Food and
Drug Administration, 1350 Piccard Dr.,
PI50–400B, Rockville, MD 20850, 301–
796–7651,
juanmanuel.vilela@fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
SUMMARY:
Substances Prohibited From Use in
Animal Food or Feed—21 CFR Part 589
(OMB Control Number 0910–0627)—
(Extension)
The final rule on bovine spongiform
encephalopathy (BSE) (73 FR 22720,
April 25, 2008) prohibits the use of
certain cattle origin materials in the
food or feed of all animals to help
prevent the spread of BSE in U.S. cattle.
BSE is a progressive and fatal
neurological disorder of cattle that
results from an unconventional
transmissible agent. BSE belongs to the
family of diseases known as
transmissible spongiform
encephalopathies (TSEs). All TSEs
affect the central nervous system of
infected animals. These measures will
further strengthen existing safeguards
against BSE.
In the Federal Register of July 28,
2011 (76 FR 45259), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. No comments were
received on the information collection.
Description of Recordkeeping for
Respondents: Rendering facilities,
medicated feed manufacturers, livestock
feeders.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1
Number of
recordkeepers
21 CFR Section
Number of
records per
recordkeeper
Average
burden per
recordkeeper
Total annual
records
Total hours
Total operating
& maintenance
costs
589.2001 (c)(2)(vi) and (c)(3)(i) ...............
589.2001 (c)(2)(ii) ....................................
589.2001 (c)(3)(i)(A) ................................
175
50
175
1
1
1
175
50
175
20
20
26
3,500
1,000
4,550
$59,500
17,000
80,580
Total ..................................................
........................
........................
........................
........................
9,050
157,080
1 There
are no capital costs associated with this collection of information.
The number of recordkeepers times
the number of records per recordkeeper
equals total annual records. Total
annual records times average burden per
recordkeeper equals total hours.
Description of Respondents for
Reporting: The final rule on BSE (73 FR
22720) included a provision that
exempts cattle materials prohibited in
animal feed (CMPAF) from designated
countries from the prohibition on its use
in animal feed (21 CFR
589.2001(b)(1)(vi)). A foreign country
seeking this designation will submit a
written request to FDA that includes a
variety of information about the
countries’ BSE status (21 CFR
589.2001(f)). FDA estimates that 10
countries could submit a request to FDA
to be exempted from CMPAF
restrictions.
FDA estimates the reporting burden
for this information collection as
follows:
emcdonald on DSK5VPTVN1PROD with NOTICES
TABLE 2—ESTIMATED ONE-TIME AND RECURRING REPORTING BURDEN 1
Number of
respondents
21 CFR Section
589.2001(b)(1) 2 ...................................................................
589.2001(f) ...........................................................................
1 There
Number of
responses
per
respondent
10
10
Total annual
responses
1
1
10
10
are no capital costs or operating costs associated with the collection of information.
burden.
2 One-time
VerDate Mar<15>2010
16:34 Oct 18, 2011
Jkt 226001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
E:\FR\FM\19OCN1.SGM
19OCN1
Average
burden per
response
80
26
Total hours
800
260
]]>Agencies
[Federal Register Volume 76, Number 202 (Wednesday, October 19, 2011)]
[Notices]
[Pages 64949-64950]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27019]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2011-N-0494]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Data To Support
Communications To Educate Consumers on How To Safely Purchase Drugs
Online
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by
November 18, 2011.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-NEW and
title ``Data to Support Communications to Educate Consumers on How to
Safely Purchase Drugs Online.'' Also include the FDA docket number
found in brackets in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850, 301-796-7651,
Juanmanuel.vilela@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Data To Support Communications To Educate Consumers on How To Safely
Purchase Drugs Online--(OMB Control Number 0910-NEW)
FDA has planned an integrated public outreach campaign to improve
the safe use of online pharmacies for drug purchases. In order to
effectively evaluate this campaign, FDA must understand individuals'
knowledge, attitudes, and practices with regard to online pharmacies
both at the start of the campaign and on an ongoing basis. This will
enable FDA to gauge progress toward educating the public on safely
purchasing from online pharmacies. An online survey panel will be
employed to collect this information, which serves the need for direct
and quantitative measurement of our target population, and which, as a
quantitative research tool has some major benefits:
To focus on our target population of adults who use the
Internet.
To collect data quickly and efficiently with minimal cost
to the government.
To reduce burden to the public by providing a means to
complete the survey at a time and place of their choosing.
FDA will use online data collection to establish a baseline and
evaluate the success of its messages and distribution methods for its
outreach campaign, which educates consumers about how to safely
purchase drugs online. Additionally, FDA will use this method to help
tailor messages and communications vehicles to have both a more
powerful and desired impact on target audiences. The data will not be
used for the purposes of making policy or regulatory decisions.
In the Federal Register of July 12, 2011 (76 FR 40920), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. FDA received no comments.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Activity Number of responses per Total annual Average burden per Total hours
respondents respondent responses response
--------------------------------------------------------------------------------------------------------------------------------------------------------
Survey Study.................................................... 5,000 1 5,000 .33 (20 min.) 1,650
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
[[Page 64950]]
Annually, FDA projects one survey study. FDA is requesting this
data collection burden so as not to restrict the Agency's ability to
gather information on public sentiment for its proposals in its
regulatory and communications programs.
Dated: October 14, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-27019 Filed 10-18-11; 8:45 am]
BILLING CODE 4160-01-P
